CRG Partners III L.P.'s Form 4 filing
T2 Biosystems, Inc. (TTOO) · filed Sep 27, 2023
- Accession no.
- 0001209191-23-050677
- Filed
- Sep 27, 2023, 5:53 PM ET
- Trade date
- Sep 25, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $62.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| CRG Partners III L.P.CIK 0001637591 | 10% Owner |
| CRG Partners III - Parallel Fund (A) L.P.CIK 0001651357 | 10% Owner |
| CR Group L.P.CIK 0001702352 | 10% Owner |
| CRG Partners III (Cayman) Lev AIV I L.P.CIK 0001767509 | 10% Owner |
| CRG Partners III (Cayman) Unlev AIV I L.P.CIK 0001767510 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Common Stock | SSaleDisposed | −99,979 | $0.25 | −$24,994.75 | 7,407,678 | Indirect | |
| Sep 25, 2023 | Common Stock | SSaleDisposed | −62,258 | $0.25 | −$15,564.5 | 4,612,840 | Indirect | |
| Sep 25, 2023 | Common Stock | SSaleDisposed | −19,996 | $0.25 | −$4,999 | 1,481,535 | Indirect | |
| Sep 25, 2023 | Common Stock | SSaleDisposed | −67,767 | $0.25 | −$16,941.75 | 5,021,014 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.